3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Papillomavirus Infections
7
Uterine Cervical Neoplasms
5
Neuroendocrine Tumors
4
Neoplasms
4
Autoimmune Diseases
3
Ovarian Neoplasms
2
Myasthenia Gravis
2
Mesothelioma, Malignant
2
Lung Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Uterine Cervical Dysplasia
1
Thyroid Diseases
1
Thrombosis
1
Squamous Intraepithelial Lesions
1
Retinal Telangiectasis
1
Renal Insufficiency
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphohistiocytosis, Hemophagocytic
1
Leukemia, Hairy Cell
1
Hemorrhage
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Interventions
Cyclophosphamide
32
Tacrolimus
29
fludarabine
27
Mycophenolic Acid
23
fludarabine phosphate
22
Busulfan
19
Whole-Body Irradiation
18
Melphalan
16
Methotrexate
15
Antilymphocyte Serum
14
Rituximab
12
Bortezomib
11
Stem Cell Transplantation
10
Cyclosporine
10
thymoglobulin
9
Sirolimus
9
Granulocyte Colony-Stimulating Factor
9
Peripheral Blood Stem Cell Transplantation
8
Thiotepa
7
Interviews as Topic
7
Filgrastim
7
Dexamethasone
7
Clofarabine
7
Blood Specimen Collection
6
Alemtuzumab
6
merphos
5
Voriconazole
5
Standard of Care
5
Nivolumab
5
Lenalidomide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hematologic Neoplasms
×
Data Collection
×
Clear all
NCT05450367
2025-09-12
PRONOSTIM
Assistance Publique - Hôpitaux de Paris
Completed
249 enrolled